155 related articles for article (PubMed ID: 12085213)
1. Orthogonal polarisation spectral imaging as a new tool for the assessment of antivascular tumour treatment in vivo: a validation study.
Pahernik S; Harris AG; Schmitt-Sody M; Krasnici S; Goetz AE; Dellian M; Messmer K
Br J Cancer; 2002 May; 86(10):1622-7. PubMed ID: 12085213
[TBL] [Abstract][Full Text] [Related]
2. Automated assessment of tumour microvascular architecture in vivo.
Becker S; Strieth S; Canis M; Preissler G; Eichhorn ME
Anticancer Res; 2010 Jul; 30(7):2597-602. PubMed ID: 20682988
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic combination tumor therapy blocking alpha(v)-integrins and VEGF-receptor-2 increases therapeutic effects in vivo.
Strieth S; Eichhorn ME; Sutter A; Jonczyk A; Berghaus A; Dellian M
Int J Cancer; 2006 Jul; 119(2):423-31. PubMed ID: 16477628
[TBL] [Abstract][Full Text] [Related]
4. The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model.
Debergh I; Van Damme N; Pattyn P; Peeters M; Ceelen WP
Br J Cancer; 2010 Mar; 102(5):837-43. PubMed ID: 20125158
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the alpha-nu integrins with a cyclic RGD peptide impairs angiogenesis, growth and metastasis of solid tumours in vivo.
Buerkle MA; Pahernik SA; Sutter A; Jonczyk A; Messmer K; Dellian M
Br J Cancer; 2002 Mar; 86(5):788-95. PubMed ID: 11875744
[TBL] [Abstract][Full Text] [Related]
6. Functional CT for quantifying tumor perfusion in antiangiogenic therapy in a rat model.
Kan Z; Phongkitkarun S; Kobayashi S; Tang Y; Ellis LM; Lee TY; Charnsangavej C
Radiology; 2005 Oct; 237(1):151-8. PubMed ID: 16183931
[TBL] [Abstract][Full Text] [Related]
7. The Cytoscan Model E-II, a new reflectance microscope for intravital microscopy: comparison with the standard fluorescence method.
Harris AG; Sinitsina I; Messmer K
J Vasc Res; 2000; 37(6):469-76. PubMed ID: 11146400
[TBL] [Abstract][Full Text] [Related]
8. Neovascular targeting chemotherapy: encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature.
Strieth S; Eichhorn ME; Sauer B; Schulze B; Teifel M; Michaelis U; Dellian M
Int J Cancer; 2004 May; 110(1):117-24. PubMed ID: 15054876
[TBL] [Abstract][Full Text] [Related]
9. Quantitative imaging of tumour blood flow by contrast-enhanced magnetic resonance imaging.
Pahernik S; Griebel J; Botzlar A; Gneiting T; Brandl M; Dellian M; Goetz AE
Br J Cancer; 2001 Nov; 85(11):1655-63. PubMed ID: 11742483
[TBL] [Abstract][Full Text] [Related]
10. Novel tubulin antagonist pretubulysin displays antivascular properties in vitro and in vivo.
Kretzschmann VK; Gellrich D; Ullrich A; Zahler S; Vollmar AM; Kazmaier U; Fürst R
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):294-303. PubMed ID: 24285578
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic agents targeting different angiogenic pathways have opposite effects on tumor hypoxia in R-18 human melanoma xenografts.
Gaustad JV; Simonsen TG; Andersen LMK; Rofstad EK
BMC Cancer; 2017 Jun; 17(1):411. PubMed ID: 28606060
[TBL] [Abstract][Full Text] [Related]
12. Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions.
Laschke MW; Elitzsch A; Vollmar B; Vajkoczy P; Menger MD
Hum Reprod; 2006 Jan; 21(1):262-8. PubMed ID: 16172144
[TBL] [Abstract][Full Text] [Related]
13. Wound-induced angiogenesis and its pharmacologic inhibition in a murine model.
Gelaw B; Levin S
Surgery; 2001 Sep; 130(3):497-501. PubMed ID: 11562675
[TBL] [Abstract][Full Text] [Related]
14. Orthogonal polarization spectral imaging versus intravital fluorescent microscopy for microvascular studies in wounds.
Langer S; Born F; Hatz R; Biberthaler P; Messmer K
Ann Plast Surg; 2002 Jun; 48(6):646-53. PubMed ID: 12055436
[TBL] [Abstract][Full Text] [Related]
15. Effects of buflomedil and pentoxifylline on hamster skin-flap microcirculation: prediction of flap viability using orthogonal polarization spectral imaging.
Coelho da Mota DS; Furtado E; Bottino DA; Bouskela E
Clinics (Sao Paulo); 2009; 64(8):797-802. PubMed ID: 19690666
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy.
Vajkoczy P; Menger MD; Vollmar B; Schilling L; Schmiedek P; Hirth KP; Ullrich A; Fong TA
Neoplasia; 1999 Apr; 1(1):31-41. PubMed ID: 10935468
[TBL] [Abstract][Full Text] [Related]
17. Contrast enhanced MRI and intravital fluorescence microscopy indicate improved tumor microcirculation in highly vascularized melanomas upon short-term anti-VEGFR treatment.
Eichhorn ME; Strieth S; Luedemann S; Kleespies A; Nöth U; Passon A; Brix G; Jauch KW; Bruns CJ; Dellian M
Cancer Biol Ther; 2008 Jul; 7(7):1006-13. PubMed ID: 18398295
[TBL] [Abstract][Full Text] [Related]
18. Static magnetic fields impair angiogenesis and growth of solid tumors in vivo.
Strelczyk D; Eichhorn ME; Luedemann S; Brix G; Dellian M; Berghaus A; Strieth S
Cancer Biol Ther; 2009 Sep; 8(18):1756-62. PubMed ID: 19633422
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine kinase inhibitor SU6668 represses chondrosarcoma growth via antiangiogenesis in vivo.
Klenke FM; Abdollahi A; Bertl E; Gebhard MM; Ewerbeck V; Huber PE; Sckell A
BMC Cancer; 2007 Mar; 7():49. PubMed ID: 17367541
[TBL] [Abstract][Full Text] [Related]
20. The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiation.
Ning S; Laird D; Cherrington JM; Knox SJ
Radiat Res; 2002 Jan; 157(1):45-51. PubMed ID: 11754641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
